56P Anti-PD1 antibody toripalimab, lenvatinib and gemox chemotherapy as first-line treatment of advanced and unresectable intrahepatic cholangiocarcinoma: A phase II clinical trial - Zhou, J; Fan, J; Shi, G (Ann Oncol, 2020)
et al.